Vanguard Personalized Indexing Management
GMAB icon

Vanguard Personalized Indexing Management’s Genmab GMAB Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Sell
49,511
-7,781
-14% -$207K 0.01% 819
2026
Q1 		$1.54M Sell
57,292
-16,362
-22% -$490K 0.02% 720
2025
Q4 		$2.27M Sell
73,654
-5,603
-7% -$175K 0.02% 555
2025
Q3 		$2.43M Buy
79,257
+26,573
+50% +$648K 0.02% 522
2025
Q2 		$1.09M Buy
52,684
+10,426
+25% +$214K 0.01% 836
2025
Q1 		$827K Buy
42,258
+7,522
+22% +$158K 0.01% 882
2024
Q4 		$725K Buy
34,736
+17,061
+97% +$375K 0.01% 939
2024
Q3 		$431K Sell
17,675
-1,619
-8% -$43.3K 0.01% 1172
2024
Q2 		$481K Sell
19,294
-468
-2% -$13.3K 0.01% 1052
2024
Q1 		$591K Buy
19,762
+5,573
+39% +$164K 0.01% 920
2023
Q4 		$452K Sell
14,189
-1,008
-7% -$31.6K 0.01% 1052
2023
Q3 		$536K Sell
15,197
-1,805
-11% -$68.8K 0.02% 848
2023
Q2 		$646K Buy
17,002
+1,088
+7% +$43.4K 0.02% 779
2023
Q1 		$601K Buy
15,914
+338
+2% +$13K 0.02% 779
2022
Q4 		$660K Buy
15,576
+1,516
+11% +$62.5K 0.03% 690
2022
Q3 		$452K Buy
14,060
+5,072
+56% +$178K 0.02% 824
2022
Q2 		$292K Buy
8,988
+1,019
+13% +$33K 0.01% 999
2022
Q1 		$288K Buy
7,969
+2,562
+47% +$87.9K 0.01% 1007
2021
Q4 		$214K Buy
5,407
+46
+0.9% +$1.92K 0.01% 974
2021
Q3 		$234K Buy
+5,361
New +$241K 0.02% 875
2021
Q2 		– Sell
-6,836
Closed -$224K – 939
2021
Q1 		$224K Sell
6,836
-1,809
-21% -$68K 0.03% 628
2020
Q4 		$352K Buy
8,645
+134
+2% +$5.01K 0.08% 307
2020
Q3 		$312K Buy
8,511
+1,844
+28% +$66.7K 0.09% 276
2020
Q2 		$226K Buy
+6,667
New +$182K 0.1% 264

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Personalized Indexing Management's GMAB Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Genmab (GMAB) stake by 14% in Q2 2026, selling an estimated $207K and leaving 49,511 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #819.

Vanguard Personalized Indexing Management first reported a position in GMAB in Q2 2020 and has held it in 24 quarters since. The position peaked at $2.43M in Q3 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Vanguard Personalized Indexing Management held 49,511 shares of Genmab worth $1.36M as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 7,781 Genmab shares in Q2 2026, an estimated $207K.
  • Genmab made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #819 holding.
  • Vanguard Personalized Indexing Management first reported a position in Genmab in Q2 2020 and has held it in 24 quarters since.
  • Vanguard Personalized Indexing Management's Genmab position peaked at $2.43M in Q3 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.